Australia Stock Investment Portal | I3investor

Neuren Pharmaceuticals Limited

ASX (AUD): Neuren Pharmaceuticals Limited (NEU)

Last Price

19.90

Today's Change

-0.20 (0.99%)

Day's Change

19.57 - 20.17

Trading Volume

284,327

Discussions

Be the first to like this. Showing 0 of 0 comments

Post a Comment

Latest Videos

New IPO: A one-stop provider of food processing and packaging machinery solutions EPB Group Bhd aims to list on the Ace Market!

MQ Trader

Apps

Send individual or group chats with anyone on i3investor

Earn MQ Points while trading with MQ Trader

MQ Affiliate

Earn side income from Affiliate Program

Online learning and teaching marketplace

Top Articles

1

CEO Morning Brief

Sydney Home Prices Hit Record High, Melbourne Slips Again

2

CEO Morning Brief

Asia to Emerge as Equity Deals Hot Spot as India Activity Surges

Hot Stocks Today >

1

1000

2

ASX Limited

1000

3

Lynas Rare Earths Limited

1000

4

Paladin Energy Ltd

666

5

Transurban Group

666

6

Enova Mining Limited

666

7

666

8

Panoramic Resources Limited

666

9

MMA Offshore Limited

666

10

Treasury Wine Estates Limited

666

Daily Stocks

0.002

0.00

169,154,805

0.001

0.00

92,317,192

0.034

0.00

39,164,564

0.009

+0.001

35,006,971

0.48

-0.005

28,583,094

0.051

0.00

27,319,811

0.91

-0.045

25,913,499

0.01

+0.001

25,480,225

3.00

+0.03

25,186,865

1.22

-0.295

23,389,094

More active Stocks

294.90

+2.82

521,003

135.87

+2.34

294,176

822.34

+2.34

648

97.30

+2.029

402,126

97.03

+2.009

225,043

92.24

+1.84

21,957

55.33

+1.67

769,285

121.11

+1.48

1,044,374

403.85

+1.20

77,721

178.91

+1.03

2,975

More gainer Stocks

315.10

-2.17

147,542

191.50

-1.25

118,425

136.98

-1.21

10,348

28.96

-1.03

30,619

46.61

-1.00

873

33.77

-0.60

853,672

30.73

-0.58

221,035

20.36

-0.56

2,028,901

12.56

-0.50

435,575

7.45

-0.42

53,373

More loser Stocks

Top Brokers >

Books Review >

Ride The Bull Short The Bear

CS Tan

4.9 / 5.0

This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....